PP405 is an oral CRTH2 receptor antagonist that blocks the prostaglandin D2 pathway responsible for follicle suppression and miniaturisation in androgenetic alopecia. Minoxidil and finasteride leave this pathway entirely unaddressed, which is why a significant...





